Malondialdehyde-modified low-density lipoprotein is a predictor of cardiac events in patients with stable angina on lipid-lowering therapy after percutaneous coronary intervention using drug-eluting stent

収録刊行物

被引用文献 (11)*注記

もっと見る

問題の指摘

ページトップへ